Vaniqa is an enzyme inhibitor used topically to slow the growth of unwanted facial hair in women. It does not remove hair.

USES
Vaniqa (Cream) is a prescription medication applied to the skin for the reduction of unwanted facial hair in women. Vaniqa interferes with an enzyme found in the hair follicle of the skin needed for hair growth. This results in slower hair growth and improved appearance where Vaniqa is applied. Vaniqa does not permanently remove hair or "cure" unwanted facial hair. It is not a depilatory. Your treatment program should include continuation of any hair removal technique you are currently using. Vaniqa will help you manage your condition and improve your appearance.

HOW TO TAKE THIS MEDICATION
Apply a thin layer of Vaniqa Cream to affected areas of the face and adjacent involved areas under the chin and rub in thoroughly. Do not wash treated area for at least 4 hours. Use twice daily at least 8 hours apart or as directed by a physician. You should continue to use hair removal techniques as needed in conjunction with Vaniqa. (Vaniqa should be applied at least 5 minutes after hair removal). Cosmetics or sunscreens may be applied over treated areas after cream has dried.

WHAT IF I MISS A DOSE?
If you forget or miss a dose of Vaniqa do not try to "make it up". Return to your normal application schedule as soon as you can.

VANIQA SIDE EFFECTS
Side effects which may go away during treatment include: stinging, burning, redness, tingling, rash of the skin or hair bumps (folliculitis). If they continue or are bothersome, check with your doctor. CONTACT YOUR DOCTOR IMMEDIATELY if you experience bleeding skin, or swelling of the face or lips. If you notice other effects not listed above, contact your doctor, nurse, or pharmacist.

PRECAUTIONS
Vaniqa may cause temporary redness, stinging, burning, tingling or rash on areas of the skin where it is applied. Hair bumps may also occur. If these persist, consult your doctor. Treatment related skin adverse events that occurred in less than 1% of the subjects treated with Vaniqa are: bleeding skin, cheilitis, and contact dermatitis, swelling of lips, herpes simplex, numbness and rosacea. Adverse events were primarily mild in intensity and generally resolved without medical treatment or discontinuation of Vaniqa.

WHAT INTERACTIONS CAN OCCUR WITH VANIQA?
Avoid getting this medication in your eyes, nose, or mouth. If this occurs, wash the area with water. If Vaniqa gets in your eyes, rinse thoroughly with water and contact your doctor.

OVERDOSE
An overdose of Vaniqa is not likely to occur. If the cream has been ingested, or if you suspect an overdose has occurred, contact your doctor, hospital emergency room, or poison control left for advice.

STORAGE
Store at 25° C (77° F); excursions permitted to 15° C-30° C (59° F-86° F). Do not freeze. See tube crimp and carton end for expiration date and lot number.